Tabla de contenido
C2HF5 17,9480 %;C3H2F4 19,3479 %;C2H2F4 21,9674 %;CH2F2 40,7367 %
Issue Date:
Last revised date:
SECTION 11: Toxicological Information
General information:
11.1 Information on toxicological effects
Acute toxicity - Oral
Product
Acute toxicity - Dermal
Product
Acute toxicity - Inhalation
Product
Component information
Pentafluoroethane
2,3,3,3-
Tetrafluoropropene
Norflurane
Difluoromethane
Repeated dose toxicity
Component information
Pentafluoroethane
Skin Corrosion/Irritation
Product
Serious Eye Damage/Eye Irritation
Product
Respiratory or Skin Sensitisation
Product
Germ Cell Mutagenicity
Product
In vitro
Component information
2,3,3,3-Tetrafluoropropene
SDS_ GB - 000010022608
SAFETY DATA SHEET
13.11.2014
22.07.2015
None.
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
LC Lo ( Rat, 4 h): > 800000 ppm Remarks: Gas
LC 50 ( Rat): > 405000 ppm
LC Lo ( Rat, 4 h): >= 567000 ppm Remarks: Inhalation
LC 0 ( Rat, 4 h): > 520000 ppm Remarks: Gas
NOEC ( Rabbit( Male)): 500 ppm
NOEC ( Rabbit( Female)): 1000 ppm
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Ames test in vitro: ( OECD Guideline 471 (Bacterial Reverse Mutation Test)):
Mutagenic
Version: 2. 0
SDS No.: 000010022608
9/16
Hide quick links:
Tabla de contenido
